Zobrazeno 1 - 10
of 38
pro vyhledávání: '"AbouYabis AN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Hematology
Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy. Moreover, there have been documented cases of hemolytic a
Autor:
Chloe S. Lalonde, Tony Z. Zhuang, Amalia A. Aldredge, Max W. Adelman, Abeer N. AbouYabis, Morgan L. McLemore, Sara C. Auld
Publikováno v:
Cancer Research. 82:444-444
Background: Immune reconstitution inflammatory syndrome (IRIS) is a rapid inflammatory response with immune recovery, most commonly observed following antiretroviral therapy initiation in people with HIV and underlying opportunistic infections. To da
Publikováno v:
Blood
Introduction: The Grady Comprehensive Sickle Cell (SC) center is the largest adult sickle cell center in the United States (US) and has the first 24/7 acute care unit for management of sickle cell vaso-occlusive events (VOE). In 2019, the center prov
Publikováno v:
In Clinical Leukemia September 2006 1(1):46-56
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
AbouYabis, Abeer N.1, Shenoy, Pareen J.2, Sinha, Rajni2, Flowers, Christopher R.2, Lechowicz, Mary Jo2 mlechow@emory.edu
Publikováno v:
ISRN Hematology. 2011, Special section p1-14. 14p.
Autor:
Abouyabis, Abeer N.1 (AUTHOR), Shenoy, Pareen J.1 (AUTHOR), Lechowicz, Mary Jo1 (AUTHOR), Flowers, Christopher R.1 (AUTHOR) christopher.flowers@emoryhealthcare.org
Publikováno v:
Leukemia & Lymphoma. Nov2008, Vol. 49 Issue 11, p2099-2107. 9p. 4 Charts, 4 Graphs.
Autor:
Mary Jo Lechowicz, Rajini Sinha, Pareen J. Shenoy, Abeer N. AbouYabis, Christopher R. Flowers
Publikováno v:
ISRN Hematology
Anthracycline-based chemotherapy remains standard treatment for peripheral T-cell lymphoma (PTCL) although its benefits have been questioned. We performed systematic literature review and meta-analyses examining the complete response (CR) and overall
Publikováno v:
Clinical Leukemia. 1:46-56
Treatment of chronic lymphocytic leukemia (CLL) has evolved over the past decade. A purine nucleoside analogue, alone or combined with other drugs, including monoclonal antibodies, is becoming the preferred first-line regimen for patients with CLL. B